To Dioselina Salto, the first two weeks of motherhood were amazing, even though she spent much of it in the hospital after ...

On Tuesday, Abbott Laboratories (ABT) stock saw a modest uptick, ending the day at $117.73 which represents a slight increase of $0.08 or 0.07% from the prior close of $117.65. The stock opened at ...

Following the robust Q3 performance, Piper Sandler raised ABT’s price target to $133 from $131, keeping an Overweight rating ...

Marie Thibault, an analyst from BTIG, reiterated the Buy rating on Abbott Laboratories (ABT – Research Report). The associated price ...

We recently made a list of UBS’ Best Stocks In The AI, Growth & Low Rates Era: Top 29 US Stocks. In this piece, we will take ...

In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other pharma stocks. Healthcare takes the concept of 'defensive' further than almost any ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

This month, we explore the 125-year-old history of Abbott Laboratories and its most significant milestone to date – the creation of its own independent company, AbbVie. In 1888, a 30-year-old ...

Barclays analyst Matt Miksic raised the firm’s price target on Abbott (ABT) to $149 from $143 and keeps an Overweight rating on the ...

Missouri Judge Sanctions Kirkland Lawyer, Barring Him from Abbott Infant Formula Trial Over Alleged Misconduct in High-Stakes NEC Case ...